94
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Six RNA Viruses and Forty-One Hosts: Viral Small RNAs and Modulation of Small RNA Repertoires in Vertebrate and Invertebrate Systems

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We have used multiplexed high-throughput sequencing to characterize changes in small RNA populations that occur during viral infection in animal cells. Small RNA-based mechanisms such as RNA interference (RNAi) have been shown in plant and invertebrate systems to play a key role in host responses to viral infection. Although homologs of the key RNAi effector pathways are present in mammalian cells, and can launch an RNAi-mediated degradation of experimentally targeted mRNAs, any role for such responses in mammalian host-virus interactions remains to be characterized. Six different viruses were examined in 41 experimentally susceptible and resistant host systems. We identified virus-derived small RNAs (vsRNAs) from all six viruses, with total abundance varying from “vanishingly rare” (less than 0.1% of cellular small RNA) to highly abundant (comparable to abundant micro-RNAs “miRNAs”). In addition to the appearance of vsRNAs during infection, we saw a number of specific changes in host miRNA profiles. For several infection models investigated in more detail, the RNAi and Interferon pathways modulated the abundance of vsRNAs. We also found evidence for populations of vsRNAs that exist as duplexed siRNAs with zero to three nucleotide 3′ overhangs. Using populations of cells carrying a Hepatitis C replicon, we observed strand-selective loading of siRNAs onto Argonaute complexes. These experiments define vsRNAs as one possible component of the interplay between animal viruses and their hosts.

          Author Summary

          Short RNAs derived from invading viruses with RNA genomes are important components of antiviral immunity in plants, worms and flies. The regulated generation of these short RNAs, and their engagement by the immune apparatus, is essential for inhibiting viral growth in these organisms. Mammals have the necessary protein components to generate these viral-derived short RNAs (“vsRNAs”), raising the question of whether vsRNAs in mammals are a general feature of infections with RNA viruses. Our work with Hepatitis C, Polio, Dengue, Vesicular Stomatitis, and West Nile viruses in a broad host repertoire demonstrates the generality of RNA virus-derived vsRNA production, and the ability of the cellular short RNA apparatus to engage these vsRNAs in mammalian cells. Detailed analyses of vsRNA and host-derived short RNA populations demonstrate both common and virus-specific features of the interplay between viral infection and short RNA populations. The vsRNA populations described in this work represent a novel dimension in both viral pathogenesis and host response.

          Related collections

          Most cited references89

          • Record: found
          • Abstract: found
          • Article: not found

          Origins and Mechanisms of miRNAs and siRNAs.

          Over the last decade, approximately 20-30 nucleotide RNA molecules have emerged as critical regulators in the expression and function of eukaryotic genomes. Two primary categories of these small RNAs--short interfering RNAs (siRNAs) and microRNAs (miRNAs)--act in both somatic and germline lineages in a broad range of eukaryotic species to regulate endogenous genes and to defend the genome from invasive nucleic acids. Recent advances have revealed unexpected diversity in their biogenesis pathways and the regulatory mechanisms that they access. Our understanding of siRNA- and miRNA-based regulation has direct implications for fundamental biology as well as disease etiology and treatment.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Argonaute2 is the catalytic engine of mammalian RNAi.

            Gene silencing through RNA interference (RNAi) is carried out by RISC, the RNA-induced silencing complex. RISC contains two signature components, small interfering RNAs (siRNAs) and Argonaute family proteins. Here, we show that the multiple Argonaute proteins present in mammals are both biologically and biochemically distinct, with a single mammalian family member, Argonaute2, being responsible for messenger RNA cleavage activity. This protein is essential for mouse development, and cells lacking Argonaute2 are unable to mount an experimental response to siRNAs. Mutations within a cryptic ribonuclease H domain within Argonaute2, as identified by comparison with the structure of an archeal Argonaute protein, inactivate RISC. Thus, our evidence supports a model in which Argonaute contributes "Slicer" activity to RISC, providing the catalytic engine for RNAi.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.

              Argonaute proteins associate with small RNAs that guide mRNA degradation, translational repression, or a combination of both. The human Argonaute family has eight members, four of which (Ago1 through Ago4) are closely related and coexpressed in many cell types. To understand the biological function of the different Ago proteins, we set out to determine if Ago1 through Ago4 are associated with miRNAs as well as RISC activity in human cell lines. Our results suggest that miRNAs are incorporated indiscriminately of their sequence into Ago1 through Ago4 containing microRNPs (miRNPs). Purification of the FLAG/HA-epitope-tagged Ago containing complexes from different human cell lines revealed that endonuclease activity is exclusively associated with Ago2. Exogenously introduced siRNAs also associate with Ago2 for guiding target RNA cleavage. The specific role of Ago2 in guiding target RNA cleavage was confirmed independently by siRNA-based depletion of individual Ago members in combination with a sensitive positive-readout reporter assay.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS Pathog
                plos
                plospath
                PLoS Pathogens
                Public Library of Science (San Francisco, USA )
                1553-7366
                1553-7374
                February 2010
                February 2010
                12 February 2010
                : 6
                : 2
                : e1000764
                Affiliations
                [1 ]Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, California, United States of America
                [2 ]Department of Gastroenterology & Hepatology, Stanford University School of Medicine, Stanford, California, United States of America
                [3 ]Department of Microbiology & Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America
                [4 ]Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, United States of America
                [5 ]Department of Plant Pathology & Microbiology, University of California at Riverside, Riverside, California, United States of America
                [6 ]Strategic Asthma Basic Research Center and the Department of Microbiology & Immunology, University of California at San Francisco, San Francisco, California, United States of America
                [7 ]Institute of Molecular Immunology, Helmholtz Center Munich, German Research Center for Environmental Health, Munich, Germany
                [8 ]Division of Infectious Diseases and Vaccinology, School of Public Health, University of California at Berkeley, Berkeley, California, United States of America
                [9 ]Stanford Genome Technology Center, Stanford University School of Medicine, Stanford, California, United States of America
                [10 ]Departments of Pediatrics & Genetics, Stanford University School of Medicine, Stanford, California, United States of America
                [11 ]Tokyo Metropolitan Organization for Medical Research, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
                [12 ]Departments of Medicine, Molecular Microbiology, Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America
                [13 ]Departments of Pathology & Genetics, Stanford University School of Medicine, Stanford, California, United States of America
                The Rockefeller University, United States of America
                Author notes
                [¤a]

                Current address: Department of Clinical Microbiology and Immunology, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, Israel

                [¤b]

                Current address: Department of Immunology, University of Washington School of Medicine, Seattle, Washington, United States of America

                [¤c]

                Current address: Sg2, Evanston, Illinois, United States of America

                [¤d]

                Current address: Harvard University, Cambridge, Massachusetts, United States of America

                [¤e]

                Current address: Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana, United States of America

                [¤f]

                Current address: Department of Microbiology and Molecular Genetics, Center for Biopreparedness and Infectious Diseases, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America

                [¤g]

                Current address: Science and Technology Policy Fellowship Program, American Association for the Advancement of Sciences, Washington, D.C., United States of America

                [¤h]

                Current address: National Veterinary Institute, Lindholm, Denmark

                [¤i]

                Current address: Laboratório de Flavivirus, Pav. Helio e Peggy Pereira, sala B 102, Instituto Oswaldo Cruz/Fundação Oswaldo Cruz, Rio de Janeiro, Brazil

                [¤j]

                Current address: Dept. of Virology, University of Heidelberg, Heidelberg, Germany

                [¤k]

                Current address: Illumina, San Diego, California, United States of America

                Conceived and designed the experiments: PP AZF. Performed the experiments: PP. Analyzed the data: PP AZF. Contributed reagents/materials/analysis tools: PP ES CW TB MAS RL KMA VH SE WJ TD SP CP FBdS RJ FB BG DG MK SK PS MR SWD EH MC MSD KK JSG AZF. Wrote the paper: PP AZF.

                Article
                09-PLPA-RA-1629R2
                10.1371/journal.ppat.1000764
                2820531
                20169186
                8654b8c5-2e8f-487c-8315-ac612516bffa
                Parameswaran et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
                History
                : 18 September 2009
                : 13 January 2010
                Page count
                Pages: 21
                Categories
                Research Article
                Genetics and Genomics/Bioinformatics
                Immunology/Immune Response
                Immunology/Innate Immunity
                Infectious Diseases/Viral Infections
                Microbiology/Innate Immunity
                Molecular Biology/Bioinformatics
                Virology/Effects of Virus Infection on Host Gene Expression
                Virology/Host Antiviral Responses

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article